{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1146.2364",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2024-06-19T01:24:11.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "CSTE Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
      "valueString" : "Trigger,Tuberculosis"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-19"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-06-19"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1146.2364"
    }
  ],
  "version" : "20240619",
  "name" : "TuberculosisPyrazinamidePZARXNORM",
  "title" : "Tuberculosis (Pyrazinamide [PZA]) (RXNORM)",
  "status" : "active",
  "date" : "2024-06-19T01:24:12-04:00",
  "publisher" : "CSTE Steward",
  "description" : "All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug),  GPCK (generic pack), or BPCK (brand pack).\nSCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This set of values contains codes for prescribable medications used as tuberculosis first line treatment drugs.),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: Pyrazinamide [PZA]),(Exclusion Criteria: none)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "198181",
            "display" : "pyrazinamide 500 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:7a18ab6b-8ca2-4e6c-a4c0-750b8613de9c",
    "timestamp" : "2025-05-23T18:44:33-04:00",
    "total" : 1,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05052025",
        "code" : "198181",
        "display" : "pyrazinamide 500 MG Oral Tablet"
      }
    ]
  }
}
